MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-02-0095802
Pharlink Labs Private Limited
Pharlink Labs Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹24.56 Cr
▲ 111% YoY
Net profit · FY 2024
₹1.65 Cr
Net margin 6.7%
EBITDA · FY 2024
₹2.73 Cr
EBITDA margin 11.1%
Authorised capital
₹70 Lakh
Registered with MCA
Paid-up capital
₹70 Lakh
Issued & subscribed
Open charges
₹2.1 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Employees · EPFO
38
Provident fund records
About Pharlink Labs Private Limited
Data last updated:
Pharlink Labs Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24290TN2016PTC113734. Its GSTIN is 33AAFCD9392Q1ZV (Tamil Nadu).
The company has an authorised share capital of ₹70 Lakh and a paid-up capital of ₹70 Lakh. It is led by directors Niranjan Karunakaran (Managing Director) and Kaviyaa.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No 23/11 1st Floor Parthasarathypuram T. Nagar, Chennai, Tamil Nadu, India – 600017.
As per the financials filed for FY 2024, the company reported a revenue of ₹24.56 Cr, a growth of 111% compared to the previous year. For the same year it recorded a net profit of ₹1.65 Cr (net margin 6.7%) and EBITDA of ₹2.73 Cr (EBITDA margin 11.1%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 15% over five years.
The company has about 38 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹2.1 Cr on record.
Pharlink Labs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0095802). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24290TN2016PTC113734
Registration Number 113734
Incorporation Date 15 December 2016
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-02-0095802
Recognitions & Rankings of Pharlink Labs
Contact details
Pharlink Labs Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo 23/11 1st Floor Parthasarathypuram T. Nagar, Chennai, Tamil Nadu, India – 600017
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Pharlink Labs Private Limited, buy the company report.
Comprehensive company report
Pharlink Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Pharlink Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Pharlink Labs Private Limited, buy the company report.
Financials of Pharlink Labs Private Limited
FY 2025 filings availablePharlink Labs Private Limited reported revenue of ₹24.56 Cr (up 111% YoY) for FY 2024.
Revenue · FY 2024
₹24.56 Cr ▲ 111%
Net profit · FY 2024
₹1.65 Cr margin 6.7%
EBITDA · FY 2024
₹2.73 Cr margin 11.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 111%
3 years · compounded
▲ 17%
5 years · compounded
▲ 15%
EBITDA CAGR growth
3 years · compounded
▲ 47%
5 years · compounded
▲ 50%
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 111% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.73 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.65 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.1% | ||||
| Net Profit Margin | 6.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pharlink Labs Private Limited, buy the company report.
Board of directors of Pharlink Labs Private Limited
Pharlink Labs has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kaviyaa | Director | 16 Aug 2023 | 3 Years 2 Months | Current |
| Niranjan Karunakaran | Managing Director | 30 Nov 2021 | 4 Years 11 Months | Current |
Peer comparison
Pharlink Labs Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Omni-Protech Drugs Private Limited | ₹24.63 Cr (FY 2025) | 4.0% | Pune, Maharashtra, India | |||
| Evinz Drugs Private Limited | ₹24.63 Cr (FY 2020) | 5.0% | Hyderabad, Telangana, India | |||
| Vats Biotech Private Limited | ₹24.62 Cr (FY 2025) | 13.0% | Jamshedpur, Jharkhand, India | |||
| Pharlink Labs Private Limitedthis company | ₹24.56 Cr (FY 2024) | ₹1.65 Cr | 6.7% | 111.0% | 38 | Chennai, Tamil Nadu, India |
| Remidex Pharma Private Limited | ₹24.56 Cr (FY 2025) | -22.0% | Bengaluru, Karnataka, India | |||
| Carewell Steuart Pharma Private Limited | ₹24.5 Cr (FY 2025) | 79.0% | Tiruvallur, Tamil Nadu, India | |||
| MRHM Pharma Private Limited | ₹24.46 Cr (FY 2024) | 10.0% | Bangalore, Karnataka, India | |||
| Sunberg Life Sciences Private Limited | ₹24.43 Cr (FY 2025) | 92.0% | Chennai, Tamil Nadu, India | |||
| Axon Drugs Private Limited | ₹24.4 Cr (FY 2024) | 4.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Pharlink Labs Private Limited, buy the company report.
Auditor
Pharlink Labs Private Limited is audited by HARI & NARAYANAN for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HARI & NARAYANAN | FY 2023 | 04885S |
Shareholding
The shareholding of Pharlink Labs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pharlink Labs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.1 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Aug 2023 | 100775822 | State Bank of India | ₹2.1 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Pharlink Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Pharlink Labs Private Limited has 11 MSME Form 1 returns on record between 2019 and 2023, listing 71 overdue payments to 19 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 19)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Sel Jegat Printers Private Limited | |||
| Hateme Plastic Industries | |||
| Sri Vaishnavi Graphics Private Limited | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Pharlink Labs Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Pharlink Labs Private Limited has a workforce of 38 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
38
Active EPFO establishments
1
Employee growth
-2.56%
GST
Pharlink Labs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAFCD9392Q1ZV | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Pharlink Labs Private Limited, buy the company report.
Recent activity
Pharlink Labs Private Limited has 5 board changes on record since 2021: 2 appointments and 3 cessations. The latest: Kaviyaa was appointed as Director on 16 Aug 2023.
AGM
Pharlink Labs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Pharlink Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with State Bank Of India amounted to Rs. 210.00 Lakh with Charge ID 100775822 was registered on 21 Aug 2023.
Appointed
Kaviyaa was appointed as Director.
Ceased
Ramkumar Palanisamy ceased to be Director.
Ceased
Niranjan Karunakaran ceased to be Director.
Appointed
Niranjan Karunakaran was appointed as Managing Director.
Ceased
Soundararajan Nivedha ceased to be Director.
Incorporation
15 Dec 2016
Pharlink Labs Private Limited was registered on 15 Dec 2016 with Roc Chennai & aged 9 years 10 months as per MCA records.
Frequently asked questions
Pharlink Labs is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 December 2016 (10+ years old) and is registered under CIN U24290TN2016PTC113734.
Pharlink Labs has 2 current directors:
- Niranjan Karunakaran - Managing Director
- Kaviyaa - Director
The latest financial statements of Pharlink Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Pharlink Labs is 33AAFCD9392Q1ZV, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Pharlink Labs is U24290TN2016PTC113734. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharlink Labs was incorporated on 15 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Pharlink Labs by revenue are Omni-Protech Drugs Private Limited, Evinz Drugs Private Limited, Vats Biotech Private Limited, Remidex Pharma Private Limited, Carewell Steuart Pharma Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kaviyaa was appointed as Director on 16 Aug 2023. Ramkumar Palanisamy ceased to be Director on 06 Dec 2021. Niranjan Karunakaran ceased to be Director on 01 Dec 2021. Pharlink Labs has 5 board changes on record in total.
Yes, Pharlink Labs is registered as a small enterprise under Udyam registration (number: UDYAM-TN-02-0095802).
Pharlink Labs has 11 MSME Form 1 returns on record between 2019 and 2023, listing 71 overdue payments to 19 micro and small suppliers. The latest return was filed on 29 Aug 2023.
The registered office of Pharlink Labs is at No 2311 1st Floor Parthasarathypuram T. Nagar, Chennai, Tamil Nadu, India – 600017.
Pharlink Labs operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages